First Mpox Case Linked to African Outbreak Reported in U.S.

Seeking AlphaNov 17 14:50

Chimerix Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow JonesNov 12 00:22 · Ratings

Chimerix Analyst Ratings

BenzingaNov 12 00:10 · Ratings

Chimerix's Dordaviprone Shows Promising Efficacy in H3 K27M-mutant Diffuse Glioma With $11 Price Target

TipRanksNov 11 22:25

Press Release: Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting

Dow JonesNov 11 20:00

Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 8 10:40 · Conference Call